Aledade
PrivateLast Round
Debt
Dec 1, 2025
Est. Valuation
$3.5B
Total Funding Raised
$1.12B
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aledade is a healthtech company that provides a platform and services for primary care organizations to improve patient outcomes and succeed in value-based care models.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Vertical SaaS, Revenue Cycle, Patient Engagement, Compliance & Risk
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aledade Comparables
Compare Aledade with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vytalize Health | 85% | |
| Astrana Health | 84% | |
| Privia Health Group Inc | 84% | |
Aledade Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 1, 2025 | ||||
| Series F | Jun 21, 2023 | ||||
| Series E | Jun 6, 2022 | ||||
| Series D | Jan 19, 2021 | ||||
| Series C | Apr 20, 2020 | ||||
Series C Extension | Oct 23, 2018 |
Key People
Founding team and executive leadership
Aledade Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OMERS | Series C, Series E, Series F |
| GV | Series B Extension, Series D, Series C, Series E |
| TEDCO | Series B Extension |
| Fidelity Management & Research Company | Series F, Series E |
| OMERS Growth Equity | Series F, Series D, Series C, Series E |
| Avidity Partners | Series F, Series E |
| Biomatics Capital Partners | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2026
Job posting suggests preparation for public-company reporting and SOX controls.
- Apr 15, 2026
Oraida Roman appointed as new Chief Commercial Officer.
Aledade Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aledade's valuation, stock price, and market status.